Application of urine cells in drug intervention for spinal muscular atrophy.

about

Application of urine cells in drug intervention for spinal muscular atrophy.

Item

http://www.wikidata.org/entity/Q41672288

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Application of urine cells in drug intervention for spinal muscular atrophy.

@en

type

Item

label

Application of urine cells in drug intervention for spinal muscular atrophy.

@en

prefLabel

Application of urine cells in drug intervention for spinal muscular atrophy.

@en

P1476

Application of urine cells in drug intervention for spinal muscular atrophy

@en

P2093

En-Lin Dong

http://www.w3.org/2001/XMLSchema#string

Jin He

http://www.w3.org/2001/XMLSchema#string

Jin-Jing Li

http://www.w3.org/2001/XMLSchema#string

Miao Zhao

http://www.w3.org/2001/XMLSchema#string

Ning Wang

http://www.w3.org/2001/XMLSchema#string

Qi-Jie Zhang

http://www.w3.org/2001/XMLSchema#string

Wan-Jin Chen

http://www.w3.org/2001/XMLSchema#string

Xin-Xin Guo

http://www.w3.org/2001/XMLSchema#string

Ying-Qian Lu

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of muscle strength and motor abilities in children with type II and III spinal muscle atrophy treated with valproic acid

SMA CARNIVAL TRIAL PART II: a prospective, single-armed trial of L-carnitine and valproic acid in ambulatory children with spinal muscular atrophy

SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy

Survival motor neuron gene 2 silencing by DNA methylation correlates with spinal muscular atrophy disease severity and can be bypassed by histone deacetylase inhibition

Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)

SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy

Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice

Beta-lactam antibiotic offers neuroprotection in a spinal muscular atrophy model by multiple mechanisms

Identification and characterization of a spinal muscular atrophy-determining gene

A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse

P304

1993-1998

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2017.4791

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Xiang Lin

P577

2017-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28962115

http://www.w3.org/2001/XMLSchema#string

P921

spinal muscular atrophy

P932

5609093

http://www.w3.org/2001/XMLSchema#string